Modulation of ischemic and bleeding risk by peripheral artery disease after an acute coronary syndrome

Back

ESC Premium Access

Modulation of ischemic and bleeding risk by peripheral artery disease after an acute coronary syndrome

Session: Translational research in acute coronary syndrome registries

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor M. Cespon Fernandez (Brussels, BE)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Maria Cespon Fernandez

University Hospital (UZ) Brussels, Brussels (Belgium)

0 follower

6 more presentations in this session

Impact of severe anemia (hemoglobin <10 g/dl) in the ischemic-bleeding profile during treatment with dual antiplatelet therapy after hospital discharge for acute coronary syndrome

Speaker: Mrs I. Munoz Pousa (Vigo, ES)

Temporal trends in latecomer ST-segment elevation myocardial infarction patients: Insights from the AMIS Plus Registry 1997-2017

Speaker: Doctor M. Roberto (Biel, CH)

Optimal timing of invasive coronary angiography following NSTEMI

Speaker: Doctor T. Mahendiran (Aalst, BE)

Benefit of modern P2Y12-inhibitors on long-term prognosis in patients with ST-elevation myocardial infarction with and without advanced chronic kidney disease

Speaker: Doctor J. Schmucker (Bremen, DE)

FFR guided acute complete revascularization versus culprit lesion only treatment in patients presenting with STEMI; 3-year cost-analysis data from COMPARE-ACUTE trial

Speaker: Doctor P. Smits (Rotterdam, NL)

Access the full session

Translational research in acute coronary syndrome registries

Speakers: Doctor M. Cespon Fernandez, Mrs I. Munoz Pousa, Doctor M. Roberto, Doctor T. Mahendiran, Doctor J. Schmucker...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Modulation of ischemic and bleeding risk by peripheral artery disease after an acute coronary syndrome

About the speaker

Doctor Maria Cespon Fernandez

6 more presentations in this session

Impact of severe anemia (hemoglobin <10 g/dl) in the ischemic-bleeding profile during treatment with dual antiplatelet therapy after hospital discharge for acute coronary syndrome

Temporal trends in latecomer ST-segment elevation myocardial infarction patients: Insights from the AMIS Plus Registry 1997-2017

Optimal timing of invasive coronary angiography following NSTEMI

Benefit of modern P2Y12-inhibitors on long-term prognosis in patients with ST-elevation myocardial infarction with and without advanced chronic kidney disease

FFR guided acute complete revascularization versus culprit lesion only treatment in patients presenting with STEMI; 3-year cost-analysis data from COMPARE-ACUTE trial

Access the full session

Translational research in acute coronary syndrome registries

About the event

ESC Congress 2019

ESC 365 is supported by